Reimbursement in forefront as industry, public policy issue

Wary of government controls, economist cites value model

Facing uncertainties, planning seen as key to product process

Common ground seen in idea generation, product portfolio

Corporate chiefs offer views on leadership, other topics

Execs share lessons learned, with seriousness and laughs

Parallel FDA/CMS reviews? Bring them on, says Schultz

Panel: Embrace compliance, because 'they're out to get you'

Lots of dialogue being heard about device deals, financings

Panel: Embrace compliance, because 'they're out to get you'